Fairmount Funds Management LLC Diversified Active

CIK: 0001802528 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value ($000): $581,469 (100.0% shares, 0.0% debt)

Holdings (16)

AXSM AXSOME THERAPEUTICS INC 21.3%

Value ($000) $124,078 Shares 2,011,647 Est. Cost $45.81 Unrealized +43.4%

NUVL NUVALENT INC 12.9%

Value ($000) $75,256 Shares 2,884,492 Est. Cost $22.67 Unrealized +30.5%

— VERONA PHARMA PLC 10.8%

Value ($000) $62,799 Shares 3,127,429 Est. Cost $10.63 Unrealized —

ONC BEIGENE LTD 8.9%

Value ($000) $51,607 Shares 239,443 Est. Cost $198.98 Unrealized —

ELVN ENLIVEN THERAPEUTICS INC 7.2%

Value ($000) $42,156 Shares 1,924,938 Est. Cost $20.34 Unrealized 0.0%

VRDN VIRIDIAN THERAPEUTICS INC 6.0%

Value ($000) $34,843 Shares 1,369,623 Est. Cost $15.80 Unrealized +103.0%

COGT COGENT BIOSCIENCES INC 5.1%

Value ($000) $29,769 Shares 2,758,975 Est. Cost $9.18 Unrealized +39.4%

ARGX ARGENX SE 4.7%

Value ($000) $27,394 Shares 73,526 Est. Cost $266.01 Unrealized —

— ASTRIA THERAPEUTICS INC 4.3%

Value ($000) $25,289 Shares 1,901,397 Est. Cost $11.99 Unrealized —

TERN TERNS PHARMACEUTICALS INC 4.2%

Value ($000) $24,154 Shares 2,040,000 Est. Cost $3.72 Unrealized +157.2%

TYRA TYRA BIOSCIENCES INC 3.9%

Value ($000) $22,771 Shares 1,416,998 Est. Cost $14.88 Unrealized -20.1%

— THESEUS PHARMACEUTICALS INC 2.8%

Value ($000) $16,567 Shares 1,865,671 Est. Cost $8.88 Unrealized —

GERN GERON CORP 2.7%

Value ($000) $15,416 Shares 7,104,358 Est. Cost $2.84 Unrealized 0.0%

— DBV TECHNOLOGIES SA 2.1%

Value ($000) $11,940 Shares 7,064,964 Est. Cost $2.30 Unrealized —

TRVI TREVI THERAPEUTICS INC 1.8%

Value ($000) $10,539 Shares 5,696,515 Est. Cost $3.04 Unrealized -25.7%

— MERUS N V 1.2%

Value ($000) $6,890 Shares 374,435 Est. Cost $18.40 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
AXSM	AXSOME THERAPEUTICS INC	2,011,647	$124,078	21.3%	$45.81	+43.4%	COM	05464T104
NUVL	NUVALENT INC	2,884,492	$75,256	12.9%	$22.67	+30.5%	COM	670703107
—	VERONA PHARMA PLC	3,127,429	$62,799	10.8%	$10.63	—	SPONSORED ADS	925050106
ONC	BEIGENE LTD	239,443	$51,607	8.9%	$198.98	—	SPONSORED ADR	07725L102
ELVN	ENLIVEN THERAPEUTICS INC	1,924,938	$42,156	7.2%	$20.34	0.0%	COM	29337E102
VRDN	VIRIDIAN THERAPEUTICS INC	1,369,623	$34,843	6.0%	$15.80	+103.0%	COM	92790C104
COGT	COGENT BIOSCIENCES INC	2,758,975	$29,769	5.1%	$9.18	+39.4%	COM	19240Q201
ARGX	ARGENX SE	73,526	$27,394	4.7%	$266.01	—	SPONSORED ADR	04016X101
—	ASTRIA THERAPEUTICS INC	1,901,397	$25,289	4.3%	$11.99	—	COM	04635X102
TERN	TERNS PHARMACEUTICALS INC	2,040,000	$24,154	4.2%	$3.72	+157.2%	COM	880881107
TYRA	TYRA BIOSCIENCES INC	1,416,998	$22,771	3.9%	$14.88	-20.1%	COM	90240B106
—	THESEUS PHARMACEUTICALS INC	1,865,671	$16,567	2.8%	$8.88	—	COM	88369M101
GERN	GERON CORP	7,104,358	$15,416	2.7%	$2.84	0.0%	COM	374163103
—	DBV TECHNOLOGIES SA	7,064,964	$11,940	2.1%	$2.30	—	SPONSORED ADR	23306J101
TRVI	TREVI THERAPEUTICS INC	5,696,515	$10,539	1.8%	$3.04	-25.7%	COM	89532M101
—	MERUS N V	374,435	$6,890	1.2%	$18.40	—	COM	N5749R100